98931-07-8
ChemmineR-0127140935XD

 22 25  0  0  0  0            999 V2000
   -5.3914   -0.5742    0.0000 C   0  0
   -4.3376    0.0000    0.0000 C   0  0
   -3.0570   -0.8262    0.0000 C   0  0
   -1.7557    0.0000    0.0000 C   0  0
   -1.7557    1.3839    0.0000 C   0  0
   -0.4751    2.1275    0.0000 C   0  0
    0.7849    1.3839    0.0000 C   0  0
    2.1895    1.8383    0.0000 C   0  0
    3.0570    0.6403    0.0000 N   0  0
    4.5555    0.6338    0.0000 C   0  0
    5.3125    1.9297    0.0000 C   0  0
    6.5125    1.9243    0.0000 C   0  0
    2.1895   -0.5370    0.0000 C   0  0
    2.4993   -1.9623    0.0000 C   0  0
    0.8262   -3.0570    0.0000 C   0  0
   -0.4338   -2.3134    0.0000 C   0  0
   -0.4751   -0.8262    0.0000 C   0  0
    0.8056    0.0000    0.0000 C   0  0
   -3.0570    2.1275    0.0000 N   0  0
   -4.3376    1.3839    0.0000 C   0  0
   -3.0671    3.6284    0.0000 C   0  0
   -3.0752    4.8284    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17  4  1  0
 17 18  2  0
 18  7  1  0
 18 13  1  0
  5 19  1  0
 19 20  1  0
 20  2  1  0
 19 21  1  0
 21 22  3  0
M  END
> <canonical_smiles>
CC1CC2C(Cc3cn(CC=C)c4cccc2c34)N(C1)C#N

> <CAS_NO>
98931-07-8

> <Source>
CCRIS

> <Activity>
1

> <WDI_Name>
.

> <REFERENCE>
GLATT,H, PERTZ,H, KASPER,R AND EICH,E, CLAVINE ALKALOIDS ANDDERIVATIVES AS MUTAGENS DETECTED IN THE AMES TEST, ANTI-CANCER DRUGS3(6):609-614, 1992

> <MC_Example>
0

> <MC_Pred>
0

> <DEREK_Example>
0

> <DEREK_Pred>
0

> <Molecular_Weight>
291.39014

> <Set>
CV4 __  __ 

$$$$
